Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 7915.1 Million | USD 11231.16 Million | 7.7% | 2023 |
The global Diabetic Shoes Market was worth around USD 7915.1 Million in 2021 and is estimated to grow to about USD 11231.16 billion by 2028, with a compound annual growth rate (CAGR) of approximately 7.7 percent over the forecast period. The report analyzes the digital remittance market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the digital remittance market.
People with diabetes may have a false sense of security in their feet as to how much at risk their feet really are. An ulcer under the foot can develop in just a couple of hours. The primary goal of diabetic shoes is to prevent complications, which can include strain, ulcers, calluses, or even amputations for patients with diabetes and poor circulation. The disease can also change the shape of a person's feet, which limits the range of shoes that can be worn comfortably. Therefore, diabetic shoes are a good alternative for such people. They are also referred to as extra depth, therapeutic shoes, or Sugar Shoes. They are often wider and deeper than regular shoes to accommodate a special multi-density supplement that is designed to reduce pressure and callouses to the bottom of the feet.
Diabetes mellitus is a persistent disease caused by acquired or is inherited as a deficiency in the assembly of insulin by the pancreas. Diabetes is classified as gestational diabetes, type 1, and type 2. Among them, type 2 diabetes is most common and is caused due to the reduction in physical activities and obesity. A person suffering from diabetes develops several complications such as ulcers, sores, loss of sensation in body parts, abscesses, and predominantly in feet. Therefore, the special design of diabetic shoes helps to protect the patient’s feet from any injuries. According to the World Health Organization (WHO), as of now, around 150 million people have diabetes mellitus across the world and by 2025; this estimated number may double. Hence, this data represents the rising prevalence of diabetes mellitus across the globe indicating the need for diabetic shoes, in turn, contributing to the growth of the global diabetic shoes market during the forecast period.
Exceptional properties of diabetic shoe aid to cure several types of the diabetic conditions such as insufficient blood circulation in body parts especially in legs, which facilitates foot pain and ulcers. The primary reason behind the growth of the diabetic shoes market is the busy lifestyle of urban people along with increased ingestion of sugar and other synthetic sweeteners. Likewise, growing geriatric population results in high incidence of diabetes, increasing cases of diabetes and rising spending on diabetes treatment is expected to fuel the global market of diabetic shoes over the forecast period. However, the expensive price of the diabetic shoes may restrain the growth of the global market growth.
The rising prevalence of diabetes globally is expected to fuel the demand for the diabetic shoes market. The total number of individuals living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Hence, increased demand for recreational diabetic shoes among diabetes patients is powering the sales in the market. As people are becoming more aware of the value of physical health, patients with diabetes and other orthopaedical problems are increasing the adoption of diabetic shoes.
The COVID-19 pandemic’s impact on the diabetic footwear market was rather negative. The supply chain commotion caused a negative impact on the market. The shutdown of manufacturing units due to lockdown restrictions also had adverse effects on the diabetic shoes market growth. European countries such as Germany, Poland, the U.K., Italy, and France are the prominent regional markets in terms of both production and consumption. These countries are most profoundly impacted by COVID-19.
Rising prevalence of diabetes disease
The major driver for the growth of diabetes shoes market is the aging population and the rising prevalence of the disease globally. Moreover, as people are becoming more aware and health-conscious, the market is expected to grow at a rapid rate. Additionally, the rise in the role of e-commerce and brand expansion in diabetic footwear, the rise in the research and development activities, and the increase in the technological advancements and modernization in the production techniques will further create new opportunities for the diabetic shoes market the in the forecast period.
High cost of diabetic footwear
The high cost of diabetic footwear is one of the major challenges for the industry players, which is limiting the growth of sales. In developing nations, less mindfulness about diabetic footwear and less per capita income compared to other developed nations are the major constraints against the demand for diabetic footwear.
The global diabetic shoes market is segregated based on type, patient type, width, price range, end-user, and distribution channel.
By end-user, the market is segregated into men and women. Women held the majority of the diabetic footwear market share and are projected to hold a significant share in the global market during the forecast period. This is mainly due to the higher number of women diabetic patients. A rise in awareness among women about the effects of diabetes on the body, improvement in online retail penetration, and foot care among diabetic patients drive the growth of the market.
By Distribution Channel, the global market is bifurcated into online and offline. The offline distribution channel segment dominated the diabetic footwear market because the specialty store is a preferred choice by the consumers and healthcare professionals as these shoes require proper fitting and expert guidance before their use, which is difficult with online platforms.
Report Attributes | Report Details |
---|---|
Report Name | Diabetic Shoes Market |
Market Size in 2023 | USD 7915.1 Million |
Market Forecast in 2032 | USD 11231.16 Million |
Growth Rate | CAGR of 7.7% |
Number of Pages | 200 |
Key Companies Covered | Aetrex Worldwide, Inc., Podartis Srl., Etonic Worldwide LLC, Dr. Comfort, LLC., Advance Diabetic Solution, Apex Foot Health Industries LLC, Dr Zen Products, Inc., DARCO International, Inc, Orthofeet Inc., and Drew Shoe Corporation. |
Segments Covered | By Type, By Patient Type, By Width, By Price Range, By End-user, By Distribution Channel, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2020 |
Historical Year | 2016 to 2020 |
Forecast Year | 2021 - 2028 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America leads the global diabetic shoes market because of its massive aging population and large prevalence of type 1 and type 2 diabetes among the population, especially in the USA and Mexico which eventually results in large consumption of such products in this region. Followed by it, Europe dominates the diabetic shoes market due to an increase in the obesity levels, an increase in the number of women diabetic patients worldwide, growing improvement in online retail penetration, and a rise in the per capita income in this region. The Asia Pacific market is anticipated to expand at a significant growth rate by the end of the forecast period. In the APAC region, China is a prominent diabetic shoes market consumer and an important production base.
Some of the main competitors dominating the global Diabetic Shoes Market include
By Type
By Patient Type
By Width
By Price Range
By End-user
By Distribution Channel
By Region
FrequentlyAsked Questions
The major driver for the growth of diabetes shoes market is the aging population and the rising prevalence of the disease globally. Moreover, as people are becoming more aware and health-conscious, the market is expected to grow at a rapid rate. Additionally, the rise in the role of e-commerce and brand expansion in diabetic footwear, the rise in the research and development activities, and the increase in the technological advancements and modernization in the production techniques will further create new opportunities for the diabetic shoes market the in the forecast period.
According to the Market Research report, the global Diabetic Shoes Market was worth around USD 5915.1 billion in 2021 and is estimated to grow to about USD 9231.16069 billion by 2028, with a compound annual growth rate (CAGR) of approximately 7.7 percent over the forecast period.
North America leads the global diabetic shoes market because of its massive aging population and large prevalence of type 1 and type 2 diabetes among the population, especially in the USA and Mexico which eventually results in large consumption of such products in this region. Followed by it, Europe dominates the diabetic shoes market due to an increase in the obesity levels, an increase in the number of women diabetic patients worldwide, growing improvement in online retail penetration, and a rise in the per capita income in this region.
Some of the main competitors dominating the Diabetic Shoes Market include - Aetrex Worldwide, Inc., Podartis Srl., Etonic Worldwide LLC, Dr. Comfort, LLC., Advance Diabetic Solution, Apex Foot Health Industries LLC, Dr Zen Products, Inc., DARCO International, Inc, Orthofeet Inc., and Drew Shoe Corporation.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed